Archive for July 2026
Expanding What’s Possible in Preimplantation Screening
In early 2026, CooperSurgical launched the Select Syndrome Screen℠ Test, which detects specific additional genetic abnormalities before embryo transfer and includes 10 impactful genetic disorders that may significantly impact a child’s health or development.
Read MoreAdvancing Reproductive Genetic Testing
CooperSurgical’s comprehensive genetic testing services focus on testing for all aspects of the preimplantation journey.
Read MoreThe Myopia Collective
The Myopia Collective, an initiative founded by CooperVision and the American Optometric Association to advance childhood myopia management into the standard of care, announced the addition of 22 new Change Agents and introduced its first-ever Student Change Agent cohort.
Read MoreMADE BETTER™
Built on years of innovation, our MADE BETTER™ Promise is about making smarter, more sustainable choices for our participating contact lenses. It reflects the work we do each day, the progress we’ve made, and our ongoing dedication to a brighter future – for People + Planet.
Read MoreMiSight® 1 Day
The first and only FDA-approved soft contact lens proven to slow the progression of myopia (nearsightedness) in children, aged 8-12 at the initiation of treatment.
Read More